Edition:
United States

Stellar Biotechnologies Inc (SBOT.OQ)

SBOT.OQ on NASDAQ Stock Exchange Capital Market

1.73USD
4:00pm EDT
Change (% chg)

$0.00 (+0.00%)
Prev Close
$1.73
Open
$1.74
Day's High
$1.74
Day's Low
$1.70
Volume
7,788
Avg. Vol
146,123
52-wk High
$10.43
52-wk Low
$1.65

Latest Key Developments (Source: Significant Developments)

Stellar Biotechnologies Announces Pricing Of $5.5 Mln Public Offering
Friday, 11 May 2018 06:00am EDT 

May 11 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES ANNOUNCES PRICING OF $5.5 MILLION PUBLIC OFFERING.STELLAR BIOTECHNOLOGIES INC - STELLAR IS OFFERING UNITS AT A PRICE OF $2.65 PER UNIT.STELLAR BIOTECHNOLOGIES INC - ANNOUNCED PRICING OF A PUBLIC OFFERING OF AN AGGREGATE OF 2.1 MILLION UNITS.  Full Article

Stellar Biotechnologies Reports Q1 Loss Per Share $0.13
Wednesday, 7 Feb 2018 04:05pm EST 

Feb 7 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES REPORTS FIRST QUARTER 2018 FINANCIAL RESULTS.Q1 LOSS PER SHARE $0.13.‍TOTAL REVENUES FOR QUARTER ENDED DECEMBER 31, 2017 WERE $.02 MILLION COMPARED TO $.14 MILLION FOR SAME PERIOD IN 2016​.  Full Article

Stellar Biotechnologies Q3 loss per share $0.12
Wednesday, 9 Aug 2017 04:05pm EDT 

Aug 9 (Reuters) - Stellar Biotechnologies Inc :Stellar Biotechnologies reports third quarter 2017 financial results.Q3 loss per share $0.12.Stellar Biotechnologies Inc - total revenues were $0.02 million for quarter ended June 30, 2017 compared to $0.18 million for same period last year.Q3 earnings per share view $-0.11, revenue view $150000.00 -- Thomson Reuters I/B/E/S.  Full Article

STELLAR BIOTECHNOLOGIES Q2 LOSS PER SHARE $0.11
Tuesday, 9 May 2017 04:15pm EDT 

May 9 (Reuters) - Stellar Biotechnologies Inc ::STELLAR BIOTECHNOLOGIES REPORTS SECOND QUARTER 2017 FINANCIAL RESULTS.Q2 LOSS PER SHARE $0.11.STELLAR BIOTECHNOLOGIES INC SAYS TOTAL REVENUES WERE $0.06 MILLION FOR QUARTER ENDED MARCH 31, 2017 COMPARED TO $0.33 MILLION FOR SAME PERIOD LAST YEAR.  Full Article

Stellar Biotechnologies reports FY 2016 financial results
Wednesday, 14 Dec 2016 04:05pm EST 

Stellar Biotechnologies Inc :Stellar Biotechnologies reports fiscal year 2016 financial results.  Full Article

Stellar Biotechnologies Q3 loss per share $0.14
Tuesday, 9 Aug 2016 08:00am EDT 

Stellar Biotechnologies Inc : Q3 loss per share $0.14 .Stellar Biotechnologies reports third quarter 2016 financial results and operational highlights.  Full Article

Stellar Biotechnologies says q3 loss per share $0.14
Tuesday, 9 Aug 2016 08:00am EDT 

Stellar Biotechnologies Inc : Qtrly total revenues of $181,092 compared to $157,748 .says q3 loss per share $0.14.  Full Article

Photo

Cryptocurrency firm Stellar gets Islamic finance certification

SYDNEY California-based Stellar has received certification from Islamic scholars for its blockchain platform and related cryptocurrency, aiming to integrate the technology into the field of sharia-compliant financial products.

No consensus analysis data available.